Maravai Lifesciences Holdings Inc (OQ:MRVI)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 10770 Wateridge Circle Suite 200
Suite 200
SAN DIEGO CA 92121
Tel: N/A
Website: https://www.maravai.com
IR: See website
<
Key People
N/A    
Business Overview
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
Financial Overview
For the nine months ended 30 September 2020, MaravaiLifesciences Holdings Inc revenues increased 73% to$185.7M. Net income applicable to common stockholderstotaled $53.5M vs. loss of $2.1M. Revenues reflect NucleicAcid Production segment increase from $54.9M to $128.6M,Biologics Safety Testing segment increase of 24% to $40.8M,North America segment increase of 72% to $108.3M, Europe.
Employees: 390 as of Sep 30, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $7,690M as of Sep 30, 2020
Annual revenue (TTM): $221.71M as of Sep 30, 2020
EBITDA (TTM): $97.53M as of Sep 30, 2020
Net annual income (TTM): $47.14M as of Sep 30, 2020
Free cash flow (TTM): $57.66M as of Sep 30, 2020
Net Debt Last Fiscal Year: $283.26M as of Sep 30, 2020
Shares outstanding: 257,620,645 as of Nov 23, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.